Atrium Therapeutics shares owned by Caxton Associates
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Caxton Associates
from 13F filings
Historical chart of Caxton Associates investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atrium Therapeutics by Caxton Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $591k | 44k | 13.37 |